Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1996 Oct; 74(8): 1175–1180.
PMCID: PMC2075941

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.


Little is known regarding the activity and function of the androgen receptor (AR) in human breast cancer. In the present study AR was evaluated in untreated primary breast cancers using antisera to the amino- and carboxy-termini of the receptor and quantitated using colour video image analysis. A strong correlation between tissue concentration and percentage AR-positive cells was observed for each antiserum. However, comparison of percentage positive cells using the amino- and carboxy-terminal AR antisera in individual breast cancer specimens revealed a subset of tumours with discordantly increased staining for the carboxy terminus. These findings suggest the presence of amino-terminal-truncated AR in a proportion of breast cancer cells or presence of AR mutations or associated protein alterations that affect binding of the amino-terminal AR antiserum. Immunohistochemical expression of the androgen-regulated glycoprotein, apolipoprotein D (apo-D), was also evaluated in the breast cancer specimens. Focal positivity of apo-D staining, which did not always co-localise with AR-positive cells, was observed within breast tumours. Furthermore, no correlation was evident between percentage positive cells stained for AR and apo-D in breast cancer specimens. These findings indicate that, although apo-D expression is androgen regulated in human breast cancer cell lines in vitro, its expression in primary breast cancers may be regulated by other factors. The expression of AR in primary breast cancers also suggests that the receptor may be involved in tumour responsiveness or in abnormal responses to endocrine therapies.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD. Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J Urol. 1995 Aug;154(2 Pt 1):622–628. [PubMed]
  • Balbín M, Freije JM, Fueyo A, Sánchez LM, López-Otín C. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem J. 1990 Nov 1;271(3):803–807. [PMC free article] [PubMed]
  • Berger FG, Watson G. Androgen-regulated gene expression. Annu Rev Physiol. 1989;51:51–65. [PubMed]
  • Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol. 1995 May;52(5):459–467. [PubMed]
  • Birrell SN, Roder DM, Horsfall DJ, Bentel JM, Tilley WD. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. J Clin Oncol. 1995 Jul;13(7):1572–1577. [PubMed]
  • Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie F, Simard J. Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells. Int J Cancer. 1994 Nov 1;59(3):400–407. [PubMed]
  • BLOOM HJ, RICHARDSON WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. [PMC free article] [PubMed]
  • Brolin J, Skoog L, Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate. 1992;20(4):281–295. [PubMed]
  • Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ. Androgen receptors in breast cancer. Cancer. 1984 Dec 1;54(11):2436–2440. [PubMed]
  • Díez-Itza I, Vizoso F, Merino AM, Sánchez LM, Tolivia J, Fernández J, Ruibal A, López-Otín C. Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol. 1994 Feb;144(2):310–320. [PMC free article] [PubMed]
  • Haagensen DE, Stewart P, Dilley WG, Wells SA. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones. Breast Cancer Res Treat. 1992;23(1-2):77–86. [PubMed]
  • Hackenberg R, Hofmann J, Hölzel F, Schulz KD. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol. 1988;114(6):593–601. [PubMed]
  • Hackenberg R, Lüttchens S, Hofmann J, Kunzmann R, Hölzel F, Schulz KD. Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res. 1991 Oct 15;51(20):5722–5727. [PubMed]
  • Hall RE, Birrell SN, Tilley WD, Sutherland RL. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer. 1994;30A(4):484–490. [PubMed]
  • Husmann DA, Wilson CM, McPhaul MJ, Tilley WD, Wilson JD. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology. 1990 May;126(5):2359–2368. [PubMed]
  • Isola JJ. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol. 1993 May;170(1):31–35. [PubMed]
  • Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993 May;41(5):671–678. [PubMed]
  • Kuenen-Boumeester V, Van der Kwast TH, van Putten WL, Claassen C, van Ooijen B, Henzen-Logmans SC. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer. 1992 Oct 21;52(4):581–584. [PubMed]
  • Lambert J, Provost PR, Marcel YL, Rassart E. Structure of the human apolipoprotein D gene promoter region. Biochim Biophys Acta. 1993 Feb 20;1172(1-2):190–192. [PubMed]
  • Lea OA, Kvinnsland S, Thorsen T. Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res. 1987 Dec 1;47(23):6189–6192. [PubMed]
  • Lea OA, Kvinnsland S, Thorsen T. Improved measurement of androgen receptors in human breast cancer. Cancer Res. 1989 Dec 15;49(24 Pt 1):7162–7167. [PubMed]
  • Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron JF, Pujol H, Sultan C. Male breast cancer and the androgen receptor gene. Nat Genet. 1993 Oct;5(2):109–110. [PubMed]
  • Loda M, Fogt F, French FS, Posner M, Cukor B, Aretz HT, Alsaigh N. Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod Pathol. 1994 Apr;7(3):388–391. [PubMed]
  • López-Boado YS, Tolivia J, López-Otín C. Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J Biol Chem. 1994 Oct 28;269(43):26871–26878. [PubMed]
  • Marugo M, Bernasconi D, Miglietta L, Fazzuoli L, Ravera F, Cassulo S, Giordano G. Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). J Steroid Biochem Mol Biol. 1992 Jun;42(5):547–554. [PubMed]
  • Mazoujian G, Haagensen DE., Jr The immunopathology of gross cystic disease fluid proteins. Ann N Y Acad Sci. 1990;586:188–197. [PubMed]
  • Simard J, de Launoit Y, Haagensen DE, Labrie F. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology. 1992 Mar;130(3):1115–1121. [PubMed]
  • Steiner MS. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol. 1995 Apr;153(4):1085–1096. [PubMed]
  • Tilley WD, Buchanan G, Hickey TE, Bentel JM. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res. 1996 Feb;2(2):277–285. [PubMed]
  • Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res. 1994 Aug 1;54(15):4096–4102. [PubMed]
  • Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev. 1993 Aug;14(4):459–479. [PubMed]
  • Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1234–1238. [PMC free article] [PubMed]
  • Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet. 1992 Oct;2(2):132–134. [PubMed]
  • Zoppi S, Wilson CM, Harbison MD, Griffin JE, Wilson JD, McPhaul MJ, Marcelli M. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation. J Clin Invest. 1993 Mar;91(3):1105–1112. [PMC free article] [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    NCBI Bookshelf books that cite the current articles.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...